Device Trial Radar · NCT07898917
PureSee/Odyssey Mix-and-Match IOL
Last checked: Nov 19, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Nov 2026
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Gainesville Eye AssociatesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Sengi
- First posted
- Oct 27, 2026
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 35 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Observational, prospective, bilateral, single-arm investigator-initiated study. Single cohort at one site: TECNIS PureSee intraocular lens in the dominant eye and TECNIS Odyssey intraocular lens in the non-dominant eye. There is no control arm, and the study is not masked.
Conditions
- Cataract
Interventions
Mix-and-match PureSee/Odyssey cohortDevice
TECNIS PureSee intraocular lens in the dominant eye and a TECNIS Odyssey intraocular lens in the non-dominant eye
Primary outcomes
What the sponsor says the trial is designed to measure.
- Binocular distance-corrected intermediate visual acuity at 66 cm (3 months postoperatively).Time frame: 3 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
North Georgia Eye Associates
Gainesville, Georgia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.